“After vaccination, immunity to the virus decreases over time. As with seasonal flu, annual vaccinations can be obtained.”
Dr. Özlem Tureci, co-founder and chief medical officer of BioNTech, one of the developers of the new type of coronavirus (Covid-19) vaccine, participated as a guest on a US-based television program.
The third dose of the Covid-19 vaccine developed with Pfizer may also be needed, he said, declaring that ‘immunity to the virus decreases after a while after the vaccine’, adding that ‘there may need to be annual vaccines as in seasonal flu’, ANKA reported.
Pfizer Chairman Albert Bourla said in recent weeks that a ‘third dose of coronavirus vaccine should be given within 12 months at the latest. Corinne M. Le Goff, a senior executive at Moderna, said last week that the supportive dose of the vaccine would be administered next year.
Last month, BioNTech founders Prof. Dr. Ugur Sahin and Özlem Tureci were awarded Germany’s highest state medal, the Order of Merit, along with a live broadcast. President Frank-Walter Steinmeier presented Sahin and Tureci with their medals at a ceremony at Berlin’s Bellevue Palace, while Chancellor Angela Merkel attended the ceremony.
“Your groundbreaking discovery saves people’s lives, livelihoods, and allows us to survive socially, economically, and culturally,” Steinmeier said. “With people who are vaccinated, we can take a small step towards everyday life, the life we miss and the people we love,” he said.
Prof. Dr. Şahin stated that “drug manufacturers and governments aim to have the production capacity to vaccinate the whole world within three months of the vaccine being developed”, predicting that given the state of the current vaccine campaigns, a large part of the global population is still waiting for vaccines, this is an ambitious goal and public-private partnership is required to get there.